Special features from the Science/AAAS Custom Publishing Office
Read our COVID-19 research and news.
- Only 30%-40% of cancer patients respond to immune checkpoint inhibitor (CPI) therapies. Intestinal bugs might boost this rate—if the right microbes or metabolites can be identified.
- The COVID-19 pandemic accelerated the use of telemedicine. Time will tell if its popularity will last.
- Microbiomics goes meta: Scientists are using the DNA of all the microbes in entire ecosystems to sequence and identify new bacteria, viruses, and fungi.
- By viewing traffic accidents as though they were a disease that could be cured, China has come a long way in reducing them.
- A cryo-electron microscopy (cryo-EM) machine for all: National centers enable researchers more access to this technology.
- Bioprinting—using 3D printing technology to create living tissues and organs—are now entering labs. Next stop: the operating room.
- Quantum technology has arrived. Find out how quantum computing will come soon to a lab near you.
- Gene editing gets an upgrade with new versions of CRISPR and CRISPR alternatives (zinc-finger nucleases, TALENs, and meganucleases).
- Researchers are embracing artificial intelligence (AI) but with cautious optimism.
- Like its chemical cousin DNA, RNA undergoes modifications that regulate gene expression, giving way to a new field: epitranscriptomics.
Read all of the best Custom Publishing content from Science. Visit our Custom Publishing section for special collections, tech features, posters and more.